Director, US Portfolio & Growth Strategy

Apotex Corp.; Fort Lauderdale (FL); On-site; USD 180,000 - 240,000; Full time

Job summary

Apotex Inc. in the United States seeks a Director, U.S. Portfolio to lead commercial evaluation and strategy for pipeline and BD opportunities, focusing on inorganic growth and pre-launch value creation.

This role identifies ANDA, 505(b)(2), and complex generic opportunities through diligence, modeling, and cross-functional decision-making. As a key partner to BD and Global Portfolio, the director drives deal evaluation and executive recommendations by integrating market insights, regulatory

Qualifications

• Experience leading teams in a pharmaceutical or healthcare company.
• Experience evaluating generic opportunities and lifecycle management.
• Strong forecasting, financial modeling and deal assessment skills.
• Knowledge of regulatory pathways to bring products to market and IP landscape.

Responsibilities

• Research, integrate and translate market research into opportunities and strategies for the US business.
• Oversee US pipeline strategy including product identification and selection.
• Lead pre-launch market research, forecasting, and commercial strategy; support deal negotiations.
• Develop robust financial models to assess asset value and inform decisions.
• Synthesize cross-functional inputs into clear executive recommendations.

Skills

People leadership

Generic pharma

Market research

Forecasting

Financial modeling

Regulatory knowledge

IP landscape

Education

Bachelor’s degree

MBA or advanced degree

Tools

IQVIA

IPDAnalytics

AlphaSense

DataMonitor

Job description

Apotex Inc. in the United States seeks a Director, U.S. Portfolio to lead commercial evaluation and strategy for pipeline and BD opportunities, focusing on inorganic growth and pre-launch value creation.

This role identifies ANDA, 505(b)(2), and complex generic opportunities through diligence, modeling, and cross-functional decision-making. As a key partner to BD and Global Portfolio, the director drives deal evaluation and executive recommendations by integrating market insights, regulatory